Altimmune, Inc. (ALT) Tops Q2 EPS by 4c

Altimmune, Inc. (NASDAQ: ALT) reported Q2 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
• Hyperscale Data declares preferred stock dividends for August
• Penguin Solutions closes $750M convertible notes offering due 2031